GT Biopharma Financial Overview
GT Biopharma's market cap is currently $8.05M. The company's EPS TTM is $-0.83; its P/E ratio is -0.23; GT Biopharma is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-0.22. See an overview of income statement, balance sheet, and cash flow financials.
